Le Lézard
Classified in: Business
Subjects: MAV, FOR, CFG

Media Advisory - Prime Minister's itinerary for Friday, September 8, 2023


OTTAWA, ON, Sept. 7, 2023 /CNW/ -

Note: All times local

Singapore, Republic of Singapore



10:00 a.m.

The Prime Minister will hold a media availability.




Note for media:


  • Open coverage


12:00 p.m.

The Prime Minister will meet with the Prime Minister of Singapore, Lee Hsien Loong.




Note for media:


  • Pooled photo opportunity at the beginning of the meeting


4:10 p.m.

The Prime Minister will depart for India.




Note for media:


  • Pooled photo opportunity


New Delhi, India



7:15 p.m.

The Prime Minister will arrive in New Delhi, India.




Note for media:


  • Pooled coverage and host broadcaster


This document is also available at https://pm.gc.ca

SOURCE Prime Minister's Office


These press releases may also interest you

at 14:01
The following issues have been halted by CIRO Company: King Global Ventures Inc. TSX-Venture Symbol: KING All Issues: Yes Reason: Pending News Halt Time (ET): 1:38 PM CIRO can make a decision to impose a temporary suspension (halt) of trading in a...

at 14:00
For the first quarter ended March 31, 2024, Desjardins Group, North America's largest financial cooperative group, recorded surplus earnings before member dividends of $855 million, up $513 million from the same quarter of 2023. All business segments...

at 13:56
A2RGC, JV, an established Mentor-Protégé Agreement and Joint Venture (JV) between ARS Aleut Remediation, LLC (Aleut) and Geosyntec Consultants, Inc. (Geosyntec), proudly announces its successful bid for a small business set-aside contract awarded by...

at 13:52
LensCrafters, part of EssilorLuxottica and one of the largest optical retail brands in North America, announces the opening of the company's newest store in Cicero, New York on May 10th. LensCrafters was previously located in Great Northern Mall...

at 13:50
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:...

at 13:45
Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, today announced its standalone and consolidated results for the Fourth Quarter (Q4) and Full Year (FY) ended 31st March 2024.     Consolidated Financial...



News published on and distributed by: